Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C
- PMID: 39931049
- PMCID: PMC11808604
- DOI: 10.1016/j.gastha.2024.10.024
Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C
Figures


Similar articles
-
Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.Am J Prev Med. 2021 Feb;60(2):285-293. doi: 10.1016/j.amepre.2020.08.031. Epub 2020 Nov 19. Am J Prev Med. 2021. PMID: 33221144 Free PMC article.
-
Association of Medicaid Managed Care Drug Carve Outs With Hepatitis C Virus Prescription Use.JAMA Health Forum. 2021 Aug 27;2(8):e212285. doi: 10.1001/jamahealthforum.2021.2285. eCollection 2021 Aug. JAMA Health Forum. 2021. PMID: 35977199 Free PMC article.
-
Medicaid Subscription-Based Payment Models and Implications for Access to Hepatitis C Medications.JAMA Health Forum. 2021 Aug 27;2(8):e212291. doi: 10.1001/jamahealthforum.2021.2291. eCollection 2021 Aug. JAMA Health Forum. 2021. PMID: 35977192 Free PMC article.
-
Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and Medicaid Programs.Public Health Rep. 2020 Jul/Aug;135(1_suppl):44S-49S. doi: 10.1177/0033354920904608. Public Health Rep. 2020. PMID: 32735189 Free PMC article. Review. No abstract available.
-
[Research progress of direct-acting antiviral drugs in the treatment of chronic hepatitis C-related cirrhosis].Zhonghua Gan Zang Bing Za Zhi. 2024 Jan 20;32(1):87-90. doi: 10.3760/cma.j.cn501113-20231126-00237. Zhonghua Gan Zang Bing Za Zhi. 2024. PMID: 38320798 Review. Chinese.
References
-
- Afdhal N., et al. N Engl J Med. 2014;370(20):1889–1898. - PubMed
Publication types
LinkOut - more resources
Full Text Sources